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Abstract
Background: The decline of hematopoietic stem cell (HSC) function upon aging contributes to aging-associated
immune remodeling and leukemia pathogenesis. Aged HSCs show changes to their epigenome, such as alterations
in DNA methylation and histone methylation and acetylation landscapes. We previously showed a correlation
between high Cdc42 activity in aged HSCs and the loss of intranuclear epigenetic polarity, or epipolarity, as
indicated by the specific distribution of H4K16ac.
Results: Here, we show that not all histone modifications display a polar localization and that a reduction in H4K16ac
amount and loss of epipolarity are specific to aged HSCs. Increasing the levels of H4K16ac is not sufficient to restore
polarity in aged HSCs and the restoration of HSC function. The changes in H4K16ac upon aging and rejuvenation of
HSCs are correlated with a change in chromosome 11 architecture and alterations in nuclear volume and shape.
Surprisingly, by taking advantage of knockout mouse models, we demonstrate that increased Cdc42 activity levels
correlate with the repression of the nuclear envelope protein LaminA/C, which controls chromosome 11 distribution,
H4K16ac polarity, and nuclear volume and shape in aged HSCs.
Conclusions: Collectively, our data show that chromatin architecture changes in aged stem cells are reversible by
decreasing the levels of Cdc42 activity, revealing an unanticipated way to pharmacologically target LaminA/C
expression and revert alterations of the epigenetic architecture in aged HSCs.
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Background
Somatic stem cell activity is critical for tissue regeneration,
and the decline in stem cell function upon aging contrib-
utes to tissue attrition [1]. In particular, hematopoiesis in
the elderly presents with an aging-associated immune re-
modeling that manifests as a decrease in red blood cells
(RBC) and lymphoid cells (T and B cells) in bone marrow
(BM) and peripheral blood (PB) as well as an increase in
myeloid cells and in the incidence of leukemia. These
aging-associated changes are, at least in part, a conse-
quence of intrinsic aging of hematopoietic stem cells
(HSCs) [1–7].
Upon aging, the HSC epigenome undergoes an “epi-
genetic drift” [8–10] that comprises alterations in the
global and local DNA/histone methylation and histone
acetylation landscape [9, 11–15]. The meaning and the
consequences of this epigenetic drift for HSC aging are
overall controversially discussed. For example, it was re-
ported that there is an increase of domains that are
marked by both active (H3K4me3) and repressive
(H3K27me3) histone modifications in aged compared to
young HSCs [14]. In addition, specific alterations of
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DNA methylation were also shown to occur upon HSC
aging at genomic regions targeting genes not expressed
in stem cells but only in downstream progenitor and ef-
fector cells [9, 15]. These observations might imply that
the contribution of epigenetic changes to HSC aging
could be to some extent beyond the immediate direct
regulation of gene transcription in stem cells. Further-
more, a mechanism explaining the general impact of
aging on any epigenetic alterations is still largely miss-
ing, preventing the development of a targeted approach
to eventually improve aged stem cell function.
Previously, we reported that young and aged HSCs
differ in both the level and the polar distribution (epi-
genetic polarity or “epipolarity”) of histone 4 acetylated
on lysine 16 (H4K16ac). H4K16ac levels and epipolarity
in HSCs are regulated by the activity of the small
RhoGTPase Cdc42. Indeed, a reduction of the aging-as-
sociated elevated Cdc42 activity by a small molecule
compound CASIN (Cdc42-activity specific inhibitor)
restores H4K16ac levels and epipolarity and rejuvenates
the function of chronologically aged HSCs (Fig. 1a)
[1, 16, 17]. These data imply a tight connection be-
tween a change in levels and epipolarity of H4K16ac
and aging and rejuvenation of HSCs (Fig. 1a). The
3D distribution of specific histone post-translational
modifications (PTMs) correlates with the organization of
chromatin and the architecture of the nucleus [18–20].
Therefore, we hypothesize that alterations in H4K16ac in
aged HSCs might be linked not only to a possible regula-
tion of gene transcription, but also to the organization of
chromatin and/or chromosome architecture. So far, it
remains elusive whether chromatin and/or chromo-
some architecture is altered upon HSC aging, which
mechanisms underlie these epigenetic alterations, and
eventually whether they might represent a target in
aged stem cells.
Here, we report that changes in polarity of H4K16ac
are tightly linked to the alteration in the localization of
specifically chromosome 11 within the nucleus of HSCs
upon aging, while alterations in the level of H4K16ac
do not generally correlate with epipolarity nor with the
function of HSCs. Mechanistically, we demonstrate that
the nuclear envelope protein LaminA/C causatively
confers changes in the nuclear volume and shape, in
H4K16ac epipolarity, and in the localization of chromo-
some 11 homologs upon HSC aging in response to
changes in the activity levels of Cdc42. Consistently,
HSCs deficient of LaminA/C present with premature
aging-like phenotypes that extend to alterations in nu-
clear volume and shape, chromosome 11 homologs
localization, and H4K16ac epipolarity. Collectively, our
data unravel a novel Cdc42-LaminA/C axis that is im-
plicated in preserving chromatin architecture and func-
tion of hematopoietic stem cells upon aging.
Results and discussion
The change in the spatial distribution of H4K16ac upon
aging is linked to a change in HSC function
Aged HSCs show both a change in the overall level of
H4K16ac and a change in the spatial distribution of
H4K16ac within the nucleus (Additional file 1: Figure S1a),
which we described as a loss of epigenetic polarity (or epi-
polarity) [16] (Fig. 1a). Therefore, we also asked whether in
general other histone PTMs localize differently in HSCs
upon aging (the representative gating strategy is depicted
in Fig. 1b) or not and whether the level of a histone PTM
and its spatial distribution within the nucleus are linked.
H4K8ac, H4K5ac, and H3K27ac also displayed a polar
distribution in young HSCs, but to an overall lower fre-
quency compared to H4K16ac, and only H3K27ac
showed a significant further decline in the frequency of
cells with a polar distribution upon aging (17.9 ± 4.6% in
young HSCs and 1.1 ± 1.1% in aged). H3K4me1 and
H3K4me3 displayed no polar distribution in either
young or aged HSCs (Fig. 1c and Additional file 1:
Figure S1b-c). The data imply that the reduction of epi-
polarity in HSCs upon aging is selective and predomin-
antly affects H4K16ac. The high frequency of H4K16ac
epipolarity in young HSCs is also specific to the more
primitive stem cell population, since the level of H4K16ac
epipolarity in slightly more differentiated short-term HSCs
(ST-HSCs, sorted as lineage- c-kit+ sca1+ CD34+ Flk2-
BM cells; gating in Fig. 1b) was very low and not altered
upon aging (Additional file 1: Figure S1d).
Next, we asked whether the levels of PTMs change in
hematopoietic stem and progenitor cells (LT-HSCs,
ST-HSCs, and lymphoid multipotent progenitors or
lymphoid-primed multipotent progenitors (LMPPs),
gated as lineage- c-kit+ sca1+ CD34+ Flk2+ BM cells;
see Fig. 1b for the gating strategy) upon aging. By intra-
cellular flow cytometry, three distinct patterns were ob-
served. In the first one (that applied to H4K5ac), the level
of histone PMT was distinctly high in stem cells and was
not altered upon aging (Fig. 1d, e, h). The second pattern
(comprising H3K4me1, H3K4me3, H4K8ac, and H3
K27ac) displayed no stem cell- and aging-specific changes
in the level (Fig. 1f, i and Additional file 1: Figure S1e-j).
The third pattern was defined by H4K16ac, for which the
level was distinctly high in stem cells and decreased with
age in an HSC-specific way (Fig. 1g, j). Among the PTMs
analyzed, H4K16ac is thus distinct with respect to both
changes in polarity and level in HSCs upon aging. In
addition, our data imply that in general, changes in the
distribution and amount of histone PTMs upon aging do
not affect all PTMs uniformly.
The data do not reveal whether the change in the level
of H4K16ac or the change in its distribution or a com-
bination of both correlates with changes in the function
of HSCs upon aging. To experimentally address this
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question, we increased the level of H4K16ac in aged
HSCs to the level seen in young HSCs via in vitro
treatment of aged HSCs with 5 mM sodium butyrate
(NaB) (Fig. 1k and Additional file 1: Figure S1k). NaB
is a broad inhibitor of histone deacetylases (HDACs)
[21–23]. The level of H4K5ac and H4K8ac in aged HSCs
was not significantly affected by NaB treatment. Therefore,
the effect of NaB treatment in HSCs was relatively specific
to H4K16ac. Interestingly, as also previously reported [16],
inhibition of Cdc42 activity via CASIN at a concentration
that resulted in the rejuvenation of aged HSC function in-
creased the level of H4K16ac in stem cells as well, but not
to the level achieved by NaB treatment (Fig. 1k). While the
treatment with CASIN restored H4K16ac epipolarity, treat-
ment with NaB did not affect epipolarity in aged HSCs
(Fig. 1l, m), and aged NaB-treated HSCs remained apolar
for H4K16ac. Therefore, the level of H4K16ac does not
generally correlate with its distribution in HSCs, and both
parameters (level and polarity) are likely independent of
each other.
Next, we investigated whether increasing the level of
H4K16ac in aged HSCs without changing H4K16ac epipo-
larity via NaB treatment improves the function of aged
HSCs. To this end, 200 aged NaB-treated Ly5.2+ HSCs
were competitively transplanted alongside 3 × 105 Ly5.1+
bone marrow (BM)-supporting cells into lethally irradi-
ated Ly5.1+ recipient mice (Fig. 1n). As a control, 200
young, aged, and aged CASIN-treated Ly5.2+ HSCs were
competitively transplanted into additional sets of lethally
irradiated Ly5.1+ recipient mice. Twenty-four-week post-
transplant animals that received aged HSCs presented
with the anticipated aging-associated shift towards more
myeloid cells in PB and BM, an increase in the frequency
of donor-derived HSCs, and an overall lower donor cell
engraftment compared to young HSCs (Fig. 1o–r and
Additional file 1: Figure S1l-s) [5, 16, 24, 25]. The contri-
bution to the B- and myeloid cell pool (Fig. 1o, p), stem
cell frequency (Fig. 1r), and polarity for H4K16ac in HSCs
(Fig. 1s, t) of donor-derived cells in mice transplanted with
young and aged CASIN-treated HSCs was almost indistin-
guishable from each other and significantly different
from aged HSCs (also Additional file 1: Figure S1l-s).
CASIN-treated aged HSCs were thus rejuvenated (as
previously reported [16] and here independently repro-
duced). To note, the re-distribution (repolarization) of
H4K16ac in aged HSCs upon CASIN treatment ex vivo
was long-term stably transmitted to daughter stem cells,
since HSCs harvested from recipients 6 months after
transplantation retained a high frequency of H4K16ac epi-
polarity (Fig. 1s, t).
In contrast, HSCs treated with NaB, which restored
the level of H4K16ac in aged HSCs to the level reported
for young HSCs (Fig. 1k), without altering its polar dis-
tribution (Fig. 1l, m), remained functionally indistin-
guishable from aged HSCs for all parameters measured
(Fig. 1o–t) and were thus not rejuvenated. Therefore,
the distribution but not the amount of H4K16ac strongly
correlates with aging and rejuvenation of HSCs.
Changes in H4K16ac epipolarity are linked to changes in
chromosome 11 homologs distribution
To further investigate the duality between changes in
levels and spatial distribution of H4K16ac, we performed
chromatin immunoprecipitation sequencing (ChIP-seq) in
young, aged, and aged CASIN-treated (rejuvenated) HSCs
alongside RNA-seq profiling on the same sample set, to
inform on transcriptome changes possibly associated to
H4K16ac (Fig. 2a). In general, the H4K16ac ChIP-seq
(See figure on previous page.)
Fig. 1 The change in the spatial distribution of H4K16ac upon aging is linked to a change in HSC function. a Aging of HSCs. Cartoon scheme of
the main previous findings [16]. b Representative FACS dot plots of HSCs (Lin-c-kit+Sca-1+Flk2-CD34-), ST-HSCs (Lin-c-kit+Sca-1+Flk2-CD34+),
LMPPs (Lin-c-kit+Sca-1+Flk2+CD34+), and LSKs (Lin-c-kit+Sca-1+) gating strategy of young and aged lineage-depleted BM cells. c Percentage
of young and aged HSCs with a polar distribution of H4K16ac, H4K8ac, H4K5ac, H3K27ac, H3K4me1, and H3K4me3; n = 3–4 biological repeats;
~ 150–200 single HSCs scored per sample in total; *p < 0.001. d Representative FACS histograms of an isotype control stained sample. Gates for
LT-HSCs and ST-HSCs. Representative FACS histograms of H3K5ac (e), H3K4me3 (f), and H4K16ac (g) of young and aged samples. LT-HSCs and
ST-HSCs gates are shown. Median fluorescence intensity of H3K5ac (h), H3K4me3 (i), and H4K16ac (j) plotted as a percentage of young control in
young and aged HSCs, ST-HSCs, and LMPPs. Shown are mean values + 1 SE; n = 4–7 biological repeats; *p < 0.05. k Median fluorescence intensity
of H4K16ac, H4K8ac, and H4K5ac plotted as a percentage of young control in young, aged, aged CASIN-treated (5 μM, 16 h), and aged NaB-
treated (5 mM, 16 h) HSCs. Shown are mean values + 1 SE; n = 4 biological repeats; *p < 0.05. l Representative distribution of H4K16ac in young,
aged, aged CASIN-treated (5 μM, 16 h), and aged NaB-treated (5 mM, 16 h) HSCs. Bar = 2 μm. Panels show DAPI (nucleus, blue), H4K16ac (red).
m Percentage of young, aged, aged CASIN-treated (5 μM, 16 h), and aged NaB-treated (5 mM, 16 h) HSCs with a polar distribution of H4K16ac;
n = 3–4 biological repeats; ~ 150–200 single HSCs scored per sample in total; *p < 0.05. n Schematic representation of the experimental setup for
HSC transplantation. Percentage of B220+ (o), myeloid (Gr1+, Mac1+, and Gr1+Mac1+) (p), and CD3+ (q) cells among Ly5.2+ donor-derived cells in
peripheral blood (PB) of recipient Ly5.1+ mice; *p < 0.05, **p < 0.01; n = 12–19. r Percentage of HSCs among donor-derived Ly5.2+ LSKs in BM of
recipient Ly5.1+ mice; *p < 0.05, **p < 0.01; n = 12–19. s Representative distribution of H4K16ac in donor-derived Ly5.2+ HSCs sorted from mice
after 24 weeks from transplant with young, aged, aged CASIN-treated (5 μM, 16 h), and aged NaB-treated (5 mM, 16 h) HSCs. Bar = 2 μm. Panels
show DAPI (nucleus, blue), H4K16ac (red). t Percentage of H4K16ac-polarized donor-derived Ly5.2+ HSCs sorted from mice after 24 weeks from
transplant with young, aged, aged+CASIN 5 μM, and aged+NaB 5 mM HSCs; n = 3 biological repeats; ~ 100–150 single HSCs scored per sample in
total; *p < 0.05, **p < 0.01
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profile in HSCs was characterized by very broad and flat
regions of enrichment (see as an example Additional file 1:
Figure S2a). Thirty-four thousand nineteen unique
H4K16ac-associated peaks were identified from all the
samples. Overall, signal intensity was decreased in
aged HSCs compared to young, consistent with a re-
duced level of H4K16ac upon aging, and only very
slightly restored in aged CASIN-treated HSCs both at
TSS and at all the other genomic regions (Fig. 2b, c).
Most of the peaks were associated with intron and
intergenic regions, and only a minority was found at
TSS and promoters (2.6% and 6.6%, respectively,
Fig. 2d). We identified 1358 H4K16ac peaks differen-
tially enriched in young vs aged HSCs and 1135 differ-
ent peaks when comparing CASIN vs aged samples
(Additional file 1: Figure S2b), and their overlap re-
sulted in 211 peaks (Fig. 2e). Out of these, 118 showed
the same direction of change (gain) for both young and
aged CASIN-treated compared to aged HSCs (see as an
example the browser tracks for Pten and Actb; Addi-
tional file 2: Table S1 and Additional file 1: Figure S2c).
Using RNA-seq profiling data (Additional file 3: Table S2),
we performed principal component analysis (PCA) based
between-group analysis (bga) and observed that aged
CASIN-treated HSC samples lie equidistantly between
young and aged samples (Additional file 1: Figure S2d and
Additional file 4: Table S3). The distance between young
and aged CASIN-treated samples reduced when we se-
lected differentially expressed genes with increasing
degree of stringency (p value < 0.05; no false discovery
rate (no FDR) adjustment, FDR with Benjamini-Hoch-
berg, and FDR with Bonferroni adjustment), indicating
that genes that are differentially expressed between
young and aged HSCs are highly similar to those in
the aged CASIN-treated vs aged HSC comparison
(Additional file 1: Figure S2d and Additional file 4:
Table S3). Similarly, heatmap based on unsupervised
hierarchical clustering further showed that aged
CASIN-treated HSCs clustered closer to young HSCs
than to aged HSCs (Additional file 1: Figure S2e). The
number of differentially expressed genes when com-
paring young and aged HSCs was 530 while 387 genes
were differentially regulated in the aged CASIN-
treated HSCs and aged HSC comparison (Add-
itional file 4: Table S3; list of differentially expressed
genes after FDR adjustment are also provided). Gene
ontology analyses did not reveal enrichment for the
hematopoietic system- or hematopoietic stem
cell-related signature (data not shown). When overall
RNA-seq data were correlated to overall H4K16ac
ChIP-seq-associated genes, correlation plots displayed
no association between overall gene expression and
global H4K16ac mark deposition (Additional file 1:
Figure S2f-g). Gene Set Enrichment Analysis (GSEA) by
taking the 211 ChIP-seq peaks overlapping between young
and CASIN as compared to aged (Fig. 2e) showed both in
young vs aged and CASIN vs aged RNA-seq dataset, no
significant enrichment between gene expression and
H4K16ac (normalized enrichment score, NES, − 1.33 and
− 1.15, respectively) (Fig. 2f). A similar conclusion was ob-
tained when considering the 1358 young vs aged and the
1135 CASIN vs aged H4K16ac-associated peaks (Add-
itional file 1: Figure S2b and h-i). Therefore, there is no
correlation of gene expression (both for overall expression
and differentially expressed genes) and H4K16ac mark de-
position changes in young and aged CASIN-treated HSCs
compared to aged HSCs.
However, among the 211 H4K16ac-associated peaks
common to young and CASIN samples compared to
aged HSCs (Fig. 2e and Additional file 2: Table S1), we
identified some selected genes known to be relevant for
HSCs and further tested their expression levels by
real-time PCR, for example, Cbx4, which has been linked to
HSC differentiation potential, Hoxb4, which is known to
play an important role in HSC self-renewal, and Mllt6,
which has been implicated in leukemia progression
[26–31]. The expression level of these selected genes
alongside a gene-specific H4K16ac peak re-deposition
was also changed in old CASIN-treated HSCs as in young
samples (Fig. 2g, h and Additional file 1: Figure S2j-m).
These data demonstrate that the H4K16ac mark might be
linked to expression differences of selected genes, imply-
ing that specific changes in H4K16ac levels might in-
deed correlate to hematopoietic-relevant transcriptional
(See figure on previous page.)
Fig. 2 Changes in H4K16ac epipolarity are linked to changes in chromosome 11 homolog distribution. a Schematic representation of the
experimental setup. Heatmaps and profiles show input-corrected H4K16ac signals ± 1.5 kb from TSS (b) and at H4K16ac peaks ± 1.0 kb (c). TSS
and peak regions were ranked by the signal intensity in young HSCs. Summary profile of n = 3 biological repeats. Each sample was generated by
pooling 50,000 sorted HSCs that were incubated 16 h in HBSS+ 10% FBS+P/S±CASIN 5 μM at 3% O2. d Pie chart showing genomic annotations
of the total 34,019 H4K16ac peaks in young, aged HSCs, and aged+CASIN 5 μM HSCs. ChIP-seq data are available at GEO Series accession number
GSE120232. e Venn diagram showing results of the cross-analysis of differentially bound H4K16ac peaks between young and aged HSCs (1358
peaks), aged+CASIN 5 μM, and aged HSCs (1135 peaks). Two hundred eleven differentially bound peaks were overlapping, and of these, 118
showed the same direction of change. f Gene Set Enrichment Analysis (GSEA) for the 211 differentially bound H4K16ac peaks overlapping
between young and CASIN HSCs as compared to aged HSCs in both young vs aged and CASIN vs aged RNA-seq dataset. RNA-seq data are
available at GEO Series accession number GSE119466. g–h UCSC browser track showing H4K16ac signal at the Cbx4 locus and real-time PCR
transcript level for Cbx4 in young, aged, and aged+CASIN 5 μM HSCs: n = 3 biological repeats, *p < 0.0001
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changes, despite the lack of a statistically significant
correlation between H4K16ac and gene expression in
HSCs.
ChIP-seq analysis allowed us to define genomic regions,
which bear different deposition (levels) of H4K16ac. How-
ever, this analysis does not inform on the 3D spatial distri-
bution of H4K16ac peaks. The change in H4K16ac
epipolarity (3D distribution) might not be due to differ-
ences in ChIP-seq mark deposition at a given genomic
locus but might imply a non-random (re-)distribution
(epipolarity) of the H4K16ac-associated genomic re-
gions within the nucleus (see example depicted in
Additional file 1: Figure S3a). While our ChIP-seq data
demonstrate that changes in H4K16ac level at given
loci are indeed detected upon HSC aging and rejuven-
ation, we also wanted to test whether a change in the
position of H4K16ac-associated genomic regions might
contribute to the change in epipolarity. To this end,
next we tested whether H4K16ac is deposited at dis-
tinct genomic regions or whether it is randomly dis-
tributed. Therefore, we analyzed the observed peak
count compared to the randomly expected distribution
relative to chromosome size and to chromosome gene
density. On a global scale, the 34,019 unique H4K16ac-as-
sociated peaks were primarily assigned to chromosomes 2,
7, and 11 (Additional file 1: Figure S3b). Interestingly,
when considering only the 118 differential peaks common
to young and CASIN-treated HSCs compared to aged
HSCs (Fig. 2e), chromosome 11 presented with a very high
non-random enrichment score, both relative to chromo-
some size (Fig. 3a) and gene density (Additional file 1:
Figure S3c). Therefore, H4K16ac peaks common to young
and CASIN-treated HSCs compared to aged HSCs are not
randomly distributed but are selectively localized on
chromosome 11.
Chromosomes are known to occupy distinct non-ran-
dom territories in interphase nuclei [32]. The nature and
position of territories are thought to play an important
role in the maintenance of the appropriate nuclear archi-
tecture and nuclear compartmentalization necessary for
proper cell function [20, 33, 34]. To test whether
H4K16ac epipolarity might correlate with a distinct
chromosome localization, we employed chromosome
full-paint DNA-FISH staining of interphase nuclei of
young, aged, and CASIN-treated HSCs to determine the
relative 3D position of the distinct chromosome territor-
ies. For these analyses, HSCs were maintained ex vivo
without growth factors for less than 16 h, and under these
conditions, HSCs remain quiescent [16, 25]. Due to the
high background generated by some of the probes, it was
not possible to reliably analyze all chromosomes’ distribu-
tion (data not shown); however, we were able to determine
the relative localization and homolog distance of chromo-
somes 3, 7, 11, and 16. While chromosome 3 homologs
showed a relatively large distance to each other, and
chromosome 7 and 16 homologs were close together, with
no difference between young and aged HSCs (Fig. 3b–d).
As there was little variation among individual cells in the
distance of distinct chromosome homologs, and distinct
homologs had distinct levels of distance, the data demon-
strated that the distribution of at least some chromosomes
in both aged and young HSCs is clearly not random.
Chromosome 11 homologs also showed a non-random
distribution and a close proximity within the nuclei of
young HSCs. Interestingly, the distance of chromosome
11 homologs to each other did significantly increase in
aged HSCs compared to young (Fig. 3e–h). Inhibition of
Cdc42 activity (via CASIN) restored the proximity of
chromosome 11 homologs in chronologically aged HSCs
to the distance reported for young HSCs (Fig. 3e–h and
Additional file 5: Video S1, Additional file 6: Video S2,
Additional file 7: Video S3), demonstrating a causative role
for the change in Cdc42 activity in regulating the position
of chromosome 11 homologs in the nucleus of HSCs.
Therefore, the data show that chromosome 11 homologs
become more distant upon aging of HSCs, and Cdc42 ac-
tivity controls the localization of chromosome territories,
specifically chromosome 11, within the nucleus of HSCs.
To test whether the change in the position of chromo-
some 11 homologs might underlie the change in H4K16ac
epipolarity in aged HSCs, we established DNA-FISH in
combination with H4K16ac IF staining (3D-Immuno-
FISH). The data revealed a high level of co-localization of
chromosome 11 and H4K16ac in young and aged CASIN-
treated HSCs (Fig. 3i, j; Additional file 1: Figure S3d and
Additional file 8: Video S4, Additional file 9: Video S5,
Additional file 10: Video S6), and both chromosome 11
homologs were close to each other in the H4K16ac-polar-
ized compartment in young and CASIN-treated HSCs. In
aged HSCs, H4K16ac was apolar and still co-localized
with chromosome 11, but to a lesser extent. As anticipated
by the low enrichment score (Fig. 3a and Additional file 1:
Figure S3c), H4K16ac showed a very weak co-localization
with chromosome 16 homologs that did not change
in aged or aged CASIN-treated HSCs (Fig. 3j and
Additional file 1: Figure S3e). In summary, the data
imply selective changes in the position of chromo-
some 11 homologs, which are linked to the loss of
H4K16ac epipolarity and the functional impairment of
HSCs upon aging.
Nuclear volume and nuclear shape are altered upon
aging of HSCs
Our data demonstrate changes in chromosome 11
homolog distribution within the nucleus upon HSC
aging, which also might be indicative of more general
changes in the nuclear architecture of aged HSCs. We
therefore determined the structure (volume and shape)
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of the nucleus of young, aged, and aged CASIN-treated
HSCs. Both 3D confocal and 3D-structured illumination
(3D-SIM) microscopy revealed that young HSCs have quite
small and highly invaginated nuclei, while in contrast, nu-
clei of aged HSCs are significantly bigger and present with
fewer invaginations. The nuclear invaginations in
young HSCs form pocket-like structures (Fig. 4a–c and
Additional file 1: Figure S4a). Upon CASIN treatment,
nuclei of chronologically aged HSCs become smaller
and highly invaginated, similar to the nuclei of young
HSCs (Fig. 4a–c). To substantiate this finding by a
genetic approach, we investigated the nuclei of HSCs
sorted from Cdc42GAP−/− mice, which present with
the constitutively increased activity of Cdc42 and show
premature aging of HSCs (Fig. 4d) [16, 35]. The nuclei
of HSCs from chronologically young Cdc42GAP−/−
mice displayed an increased nuclear volume and a de-
crease in nuclear invaginations, similar to aged HSCs
(Fig. 4e–g). Therefore, the shape and volume of HSC
nuclei are altered upon aging, and these changes are
regulated by Cdc42 activity. As a consequence, nuclear
shape and volume can be targeted by CASIN treatment
in chronologically aged HSCs.
Finally, we investigated the mechanism by which
changes in Cdc42 activity might affect these distinct epi-
genetic aspects: H4K16ac epipolarity, chromosome 11
homolog proximity, and nuclear shape and volume
which are altered upon aging of HSCs. We reasoned that
structural molecules of the nuclear envelope, like nu-
clear lamins, might be downstream targets of changes in
Cdc42 activity in HSCs. Nuclear lamins constitute the
major intermediate filament proteins underlying the
inner nuclear membrane and participate in many differ-
ent nuclear architectural aspects and in genome main-
tenance by providing a scaffold for tethering chromatin
and protein complexes that regulate genomic stability
[36]. Lamins are divided into A/C- and B types based on
their primary sequence homologies. A/C-type lamins are
encoded by a single gene (Lmna). Mutations in the gene
encoding LaminA/C, or factors affecting its maturation
and dynamics, are also known to cause accelerated aging
syndromes such as the Hutchinson-Gilford progeria syn-
drome [37]. HSCs sorted from Cdc42GAP−/− mice, which
present with constitutively increased Cdc42 activity and
premature aging-like phenotypes, showed a significantly
decreased level of LaminA/C (Fig. 4h, i), implying that
Cdc42 activity plays a role in controlling LaminA/C ex-
pression in HSCs.
LaminA/C expression in the hematopoietic system is
specific to HSCs and is decreased upon aging
A role for lamins in influencing the differentiation of
blood cells was previously described [38], and changes in
both LaminA/C and Lamin B are also known to affect
chromatin [39–41]. Therefore, intrigued by the finding
that Cdc42 activity regulates LaminA/C expression in
HSCs, we further investigated lamins in young, aged,
and aged CASIN-treated stem cells. IF analyses showed
that Lamin B was localized to the nuclear periphery,
with the pattern of distribution and the level of expres-
sion being almost identical in young, aged, and aged
CASIN-treated HSCs (Fig. 5a). Interestingly, LaminA/C
level was drastically reduced upon aging and restored to
the level found in young HSCs upon inhibition of Cdc42
activity in aged HSCs, which is consistent with the in-
crease in Cdc42 activity upon aging and with the reduc-
tion of LaminA/C expression in Cdc42GAP−/− HSCs
(Fig. 5b, c). Also, it was interesting to note that LaminA/
C showed an overall dotted pattern of distribution spe-
cifically associated with the nuclear invaginations in
(See figure on previous page.)
Fig. 3 Changes in H4K16ac epipolarity are linked to the changes in chromosome 11 homologs distribution. a Comparison of the observed peak
count and expected peak count relative to the chromosome size for the 118 peaks identified as described in panel M. Goodness of fit test was
used, and it revealed that these 118 differentially bound H4K16ac peaks are not randomly distributed and chromosome 11 presented with the
highest enrichment score. b Representative confocal 3D reconstruction of the nucleus (stained with DAPI, blue) and of chromosomes 3 (red), 7
(green), and 16 (green) by FISH stained with full-paint probe in young and aged HSCs. Bar = 2 μm. c Measurements of the distances between
chromosomes 3 (n = 3 biological repeats, 28 cells for young, 21 cells for aged in total), 7 (n = 3 biological repeats, 25 cells for young, 26 cells for
aged in total), and 16 (n = 3 biological repeats, 30 cells for young, 18 cells for aged in total) homologs in young and aged HSCs by Volocity 3D
Image Analysis Software. d Percentage of young and aged HSCs with chromosome homolog proximity for chromosomes 3, 7, and 16, n = 3
biological repeats. e Representative confocal 3D reconstruction of the nucleus (stained with DAPI, blue) and of chromosome11 (red, FISH stained
with a full-paint probe) in young, aged, and aged+CASIN 5 μM HSCs. Bar = 2 μm. f 3D reconstruction of the chromosome 11 homologs (red and
green) and the distance measurement between them by Volocity 3D Image Analysis. In young HSCs, green color for two homologs shows that
they are distributed very close to each other and are not recognized as two objects by the software. While in aged and aged+CASIN 5 μM HSCs,
they are marked as two objects in green and red. Bar = 2 μm. g Measurements of the distances between chromosome 11 homologs by Volocity
3D Image Analysis. Shown are mean values + 1 SE; *p < 0.01; n = 6 biological repeats, 64 cells for young, 58 cells for aged, and 55 cells for aged+CASIN
in total. h Percentage of young, aged, and aged+CASIN 5 μM HSCs with homolog proximity for chromosome11; **p < 0.01. i Representative confocal
3D reconstruction of young, aged, and aged+CASIN 5 μM HSCs after DNA-FISH+IF. H4K16ac (green), chromosome 11 (red), the nucleus is stained with
DAPI (blue). Bar = 2 μm. j Volume measurement of the co-localized area between H4K16ac and chromosomes 11 and 16 by Volocity 3D Image
Analysis; *p < 0.05, n = 3 biological repeats, 33 cells for young, 33 cells for aged, and 28 cells for aged+CASIN in total for chromosome 11 and 32 cells
for young, 26 cells for aged, and 19 cells for aged+CASIN in total for chromosome 16
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young and aged CASIN-treated HSCs (Fig. 5d–f and
Additional file 11: Video S7, Additional file 12: Video S8,
Additional file 13: Video S9).
Consistent with the decrease of LaminA/C in aged
HSCs, we also detected clear alterations in the nuclear
compartmentation of lamin-associated domains (LADs)
Fig. 4 Nuclear volume and nuclear shape are altered upon aging of HSCs. a Representative confocal 3D reconstruction of the nucleus (stained
with DAPI, blue) of young, aged, and aged+CASIN 5 μM HSCs. The arrowheads indicate the nuclear invagination normally observed in young and
aged+CASIN HSCs. Bar = 2 μm. b Nuclear volume measurements by 3D-structured illumination (SIM) analysis (based on DAPI staining). ***p< 0.001; n= 3
biological repeats, 47 cells for young, 44 cells for aged, and 70 cells for aged+CASIN 5 μM in total. c Nuclear shape factor (NSF) measurements by Volocity
3D Image Analysis. The NSF scores the 3D shape of an object: 1 corresponds to a perfect sphere. *p< 0.05, ***p< 0.001; n= 6 biological repeats, 62 cells for
young, 64 cells for aged, and 61 cells for aged+CASIN 5 μM in total. d Cartoon scheme summarizing premature aging-like phenotypes of Cdc42 GAP
knockout (Cdc42GAP−/−) mice. e Representative confocal 3D reconstruction of the nucleus (stained with DAPI, blue) of Cdc42GAP+/+ and Cdc42GAP−/−
HSCs. The arrowheads indicate the nuclear invagination observed in Cdc42GAP+/+ HSCs. Bar = 2 μm. f Nuclear volume measurements by Volocity 3D
Image Analysis (based on DAPI staining). ****p< 0.0001; n= 4 biological repeats, 119 cells for Cdc42GAP+/+, and 102 cells for Cdc42GAP−/− mice in total.
g Nuclear shape factor (NSF) measurements by Volocity 3D Image Analysis. The NSF scores the 3D shape of an object: 1 corresponds to a perfect sphere.
**p< 0.01, n= 4 biological repeats, 118 cells for Cdc42GAP+/+, and 101 cells for Cdc42GAP−/− mice in total. h Representative confocal 3D reconstruction of
the nucleus (stained with DAPI, blue) and of LaminA/C (green) of Cdc42GAP+/+ and Cdc42GAP−/− HSCs. Bar = 2 μm. i LaminA/C volume measurements by
Volocity 3D Image Analysis (based on LaminA/C staining). **p< 0.01; n= 3 biological repeats, 50 cells for Cdc42GAP+/+, and 50 cells for Cdc42GAP−/− mice
in total
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Fig. 5 (See legend on next page.)
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upon aging, as stained by H3K9me2 [42–44]. This repres-
sive heterochromatin-associated histone PMT displayed
marked reduction in its peripheral nuclear localization in
aged stem cells (Additional file 1: Figure S5a), which was
restored alongside the re-establishment of LaminA/C ex-
pression after CASIN treatment (Fig. 5g, h).
LaminA/C expression in young and aged ST-HSCs, as
well as in LMPPs and committed myeloid progenitors
(LK, lineage- c-kit+ sca1- BM cells; see Fig. 1b for the
gating strategy), was significantly lower compared to
HSCs (Additional file 1: Figure S5b), indicating a prom-
inent role of LaminA/C for hematopoiesis primarily to
the stem cell compartment. To further investigate the
function of LaminA/C for hematopoiesis, we crossed
Lmna flox mice with mice bearing the Vav-Cre transgene
to delete LaminA/C specifically in the hematopoietic com-
partment (LmnaΔ/Δ/Vav-Cre) (Additional file 1: Figure S5c)
[45, 46]. HSCs from young LmnaΔ/Δ/Vav-Cre mice
showed reduced levels of LaminA/C in HSCs but the
knockout was incomplete, and we reproducibly de-
tected residual LaminA/C protein (Additional file 1:
Figure S5d-f ). Nevertheless, hematopoiesis in these
mice manifested with a decrease in B cell frequency, a
reduced RBC count, a reduced concentration of he-
moglobin in PB, an increase in myeloid cell frequency,
and an elevated neutrophil count in peripheral blood (PB)
as well as in BM already by 11 months of age (Fig. 5i–k
and Additional file 1: Figure S5 g), consistent with a
hematopoietic premature aging-like phenotype.
The decrease of LaminA/C expression in HSCs determines
changes in nuclear volume and shape, H4K16ac polarity,
and chromosome 11 homologs proximity
We further analyzed aging phenotypes in LmnaΔ/Δ/Vav-Cre
HSCs, and we detected larger and odd-shaped nuclei,
similar to the nuclear shape of aged HSCs and distinct
from wild-type young controls (Fig. 6a–c). Most import-
antly, young LmnaΔ/Δ/Vav-Cre HSCs showed reduced
H4K16ac polarity and increased nuclear volume that
could not be rescued by CASIN treatment (Fig. 6d, e and
Additional file 1: Figure S6a). These data strongly link
LaminA/C expression, which is a downstream target of
Cdc42 activity levels, to changes in H4K16ac epipolarity
and nuclear volume. The absence of LaminA/C did not
alter the overall amount of H4K16ac (Fig. 6f, g). Young
LmnaΔ/Δ/Vav-Cre HSCs consequently also showed an in-
crease in the distance between chromosome11 homologs,
similar to aged HSCs (Fig. 6h–k).
Collectively, these data demonstrate that LaminA/C is
a downstream mediator of changes in Cdc42 activity in
aged HSCs. LaminA/C regulates the nuclear shape and
volume, H4K16ac epipolarity, and chromosome11 homo-
log proximity in HSCs upon aging, and consequently, low
levels of LaminA/C confer aging-associated phenotypic
and functional changes to HSCs (Fig. 6l). The data further
confirm a role for changes in polarity of H4K16ac inde-
pendent of changes in the level of this epigenetic mark, as
loss of LaminA/C changes polarity, but not the level of
H4K16ac. The data therefore imply at least a necessary
contribution of changes in the nuclear architecture for the
aging-associated changes in the function of HSCs.
Conclusions
The contribution of the epigenetic drift to changes in
the function of aged HSCs is currently the focus of in-
tense debate. Recently, we and others showed that the
function of HSCs corresponds to their epigenetic con-
figuration but not always to their transcriptional state
[47, 48], while epigenetic alterations in chromatin
architecture were shown to precede transcriptional
changes in somatic cell reprogramming [49]. These ob-
servations altogether support the concept of epigenetic
and chromatin architecture changes as an instructive
force for stem cell fate establishment that facilitates
transcriptional changes in the differentiating progeny
[50]. Our data show that the overall level and spatial
distribution of multiple histone PTMs do not change to
a large extent upon HSC aging, in agreement with the
data by others [14, 15]. Aging of HSCs is thus more
likely associated with a set of smaller local changes in
(See figure on previous page.)
Fig. 5 LaminA/C expression in the hematopoietic system is specific to HSCs and is decreased upon aging. a Representative confocal 3D reconstruction
of the nucleus (stained with DAPI, blue) and LaminB (green) of young, aged, and aged+CASIN 5 μM HSCs. Bar = 2 μm. b Representative confocal 3D
reconstruction of the nucleus (stained with DAPI, blue) and of LaminA/C (green) of young, aged, aged+CASIN 5 μM HSCs, and young ST-HSCs. Bar = 2 μm.
c Lmna transcript levels in young, aged, aged+CASIN 5 μM HSCs, and in young ST-HSCs. Shown are mean values + 1 SE; n = 3 biological
repeats; ****p < 0.0001. d Representative distribution of LaminA/C (green) in young HSCs. Bar = 2 μm. The arrow indicates LaminA/C
distribution in the deep invagination of young HSCs nuclei. e Percentage of young HSCs with invaginated nuclei, n = 4 biological repeats, 45
single HSCs in total. f Percentage of young HSCs which have LaminA/C distribution in the invagination site of HSCs nuclei out of invaginated
HSCs, n = 4 biological repeats, 45 single HSCs in total. g Representative confocal 3D reconstruction of the distribution of H3K9me2 in young,
aged, and aged CASIN-treated LT-HSCs. Bar = 2 μm. h Percentage of young, aged, and aged+CASIN 5 μM HSCs presenting with peripheral
heterochromatin localization of H3K9me2, n = 3 biological repeats, ~ 150 single HSCs for young and aged, 20 single HSCs for aged+CASIN
5 μM in total; *p < 0.05. i Representative FACS dot plots of B220+, CD3+, and myeloid (Gr1+, Mac1+, and Gr1+Mac1+) cells in control Lmnafl/fl
and LmnaΔ/Δ/Vav-Cre PB. j Percentage of B220+, CD3+, and myeloid (Gr1+, Mac1+, and Gr1+Mac1+) cells in PB of control Lmnafl/fl and LmnaΔ/Δ/Vav-Cre
mice; *p < 0.05, n = 4–6 mice. k Hematologic analyses of control Lmnafl/fl and LmnaΔ/Δ/Vav-Cre mice. *p < 0.05, **p < 0.01; n = 5–6 mice
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the epigenetic make-up rather than a general global
drift. Our data provide further support for a view in
which changes in the level of a specific histone PTM
(H4K16ac) per se do not affect HSC function upon aging,
as increasing levels of histone acetylation in aged HSCs
(like for example after NaB treatment, see Fig. 1k, n–t) do
not rejuvenate stem cell function in transplantation assays.
The fact that young LmnaΔ/Δ/Vav-Cre HSCs present with a
premature aging phenotype in the absence of a change in
H4K16ac levels (see Fig. 6f, g) even support a model in
which changes in the level of H4K16ac might actually be
dispensable for conferring aging phenotypes on HSCs.
Interestingly, our findings underlie that chromatin and
epigenetic architecture changes in aged stem cells are
correlated to the functional alteration of HSCs upon
aging and are reversible by targeting LaminA/C expres-
sion via Cdc42 activity. Indeed, we show that changes in
the localization of at least chromosome 11 territories in
aged HSCs are related to the shift from a polar to an
apolar distribution of the H4K16ac mark upon aging
and correlate to the functional impairments in aged and
in LmnaΔ/Δ/Vav-Cre HSCs. Pharmacological treatment
with CASIN restores chromosome 11 architecture in
aged HSCs and also improves old stem cell function in
transplantation assays. To note, quantitative trait loci on
chromosome 11 have been previously linked to aging in
hematopoiesis as well as lifespan [51, 52]. Moreover, the
frequency of HSCs in BM, known to be affected by
chronological aging, is also associated with a locus on
murine chromosome 11 [53].
In addition, here we identify the increase in nuclear
volume and a change in the nuclear shape as novel phe-
notypes of aged HSCs. The genome forms an ordered,
hierarchical structure that is believed, by orchestrating
the nuclear architecture and the relative positions of chro-
mosomes, to also orchestrate important cell biological
functions [54–56]. Along with this line, our data provide a
strong correlation between changes in nuclear volume
and shape and in the position of specifically chromosome
11 homologs and changes in the function of HSCs. Our
data also imply that these architectural changes are neces-
sary and precede the alterations of HSC function upon
aging, while their reversal is linked to HSC rejuvenation.
However, the relationship between changes in the nuclear
shape, nuclear volume, and chromosome 11 homolog pos-
ition will need to be further investigated in a more strin-
gent mechanistic approach.
Changes in nuclear volume and shape, changes in the
distance of chromosome 11 homologs, and changes in
H4K16ac epipolarity are a consequence of changes in
LaminA/C expression. The reduction of LaminA/C in
chronological young HSCs (LmnaΔ/Δ/Vav-Cre) consequently
confers a segmental premature aging-like phenotype to
HSCs. LaminA/C is known to be in close contact with
large chromatin domains named lamina-associated do-
mains (LADs). LADs are thought to help organize chro-
mosomes inside the nucleus and have been associated
with gene repression [42]. It has been reported that
H3K9me2 and me3 have a prominent role in anchoring
LADs to nuclear LaminA/C [57]. Consistent with the re-
duction in LaminA/C expression upon aging, we report
here the alteration in H3K9me2 peripheral localization in
aged HSCs while other reported a decrease in H3K9me3
[58], also supporting the overall alterations in the hetero-
chromatin compartmentalization. As well, others recently
described a role for LaminA/C in facilitating the func-
tional organization of chromosomes, although not for
stem cells or the aging of stem cells [59]. Alterations in
LaminA/C in mesenchymal stem cells were also impli-
cated in the deregulation of canonical Wnt/Notch signal-
ing [60]. Interestingly, we previously reported an intrinsic
autocrine switch from canonical to non-canonical Wnt
(See figure on previous page.)
Fig. 6 The decrease of LaminA/C expression in HSCs determines changes in nuclear volume and shape, H4K16ac polarity, and chromosome 11
homolog proximity. a Representative confocal 3D reconstruction of the nucleus (stained with DAPI, blue) of Lmnafl/fl and LmnaΔ/Δ/Vav-Cre HSCs.
Bar = 2 μm. b Nuclear volume measurements by Volocity 3D Image Analysis (based on DAPI staining). **p < 0.01; n = 8 biological repeats; 100
single HSCs for Lmnafl/fl, 115 single HSCs for LmnaΔ/Δ/Vav-Cre in total. c Nuclear shape factor (NSF) measurements. *p < 0.05; n = 4 biological
repeats; 99 HSCs for Lmnafl/fl, 100 HSCs for LmnaΔ/Δ/Vav-Cre in total. d Representative distribution of H4K16ac in Lmnafl/fl, LmnaΔ/Δ/Vav-Cre, LmnaΔ/Δ/
Vav-Cre + CASIN 5 μM, aged, and aged+CASIN 5 μM HSCs. Bar = 2 μm. Panels show DAPI (nucleus, blue), H4K16ac (red). e Percentage of Lmnafl/fl,
LmnaΔ/Δ/Vav-Cre, LmnaΔ/Δ/Vav-Cre + CASIN 5 μM, aged, and aged+CASIN 5 μM HSCs with a polar distribution of H4K16ac. Shown are mean values + 1 SE;
n = 3–5 biological repeats, ~ 30–100 single HSCs scored per sample in total; *p < 0.05, ***p < 0.001. f Representative FACS histograms of an isotype
control stained sample and of H4K16ac in Lmnafl/fl and LmnaΔ/Δ7Vav-Cre samples. HSCs gates are shown. g Median fluorescence intensity of H4K16ac in
HSCs of control Lmnafl/fl and LmnaΔ/Δ/Vav-Cre mice; n = 3 biological repeats. h Measurements of the distances between chromosome 11 homologs in
Lmnafl/fl and LmnaΔ/ΔVav-Cre HSCs by Volocity 3D Image Analysis; **p < 0.01; n = 3 biological repeats, 27 cells for Lmnafl/fl, 30 cells for LmnaΔ/Δ/Vav-Cre in
total. i Percentage of Lmnafl/fl and LmnaΔ/Δ/Vav-Cre HSCs with chromosome homologs proximity for chromosome 11; n = 3 biological repeats; *p < 0.05.
j Representative confocal 3D reconstruction of the nucleus (stained with DAPI, blue) and of chromosome 11 (red, FISH stained with a full-paint probe)
in Lmnafl/fl and LmnaΔ/Δ/Vav-Cre HSCs. Bar = 2 μm. k 3D reconstruction of the chromosome 11 homologs (red and green) and the distance
measurement between them by Volocity 3D Image Analysis. In Lmnafl/fl HSCs green, color for two homologs shows that they are distributed very
close to each other and are not recognized as two objects by the software. While in LmnaΔ/Δ/Vav-Cre HSCs, they are marked as two objects in green
and red. Bar = 2 μm. l Summary of premature aging-like phenotypes in the hematopoietic system of LaminA/C conditional knockout mice. m Aging
of HSCs compartment. Cartoon scheme integrating the novel main findings. The newly identified HSC aging phenotypes are highlighted in red
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signaling in HSCs upon aging that results in elevated ac-
tivity of Cdc42 [25, 60]. We also demonstrate that the ac-
tivity of Cdc42 controls the expression of LaminA/C in
HSCs, since LaminA/C is increased in aged HSCs treated
with CASIN (which lowers Cdc42 activity) and decreased
in young Cdc42GAP−/− HSCs, which present with consti-
tutively increased activity of Cdc42 and a premature
aging-like phenotype [16, 35]. Therefore, the data establish
a Cdc42-LaminA/C regulation of the nuclear and chroma-
tin architecture in HSCs. Importantly, in addition, we
show here that chromatin architecture changes are revers-
ible by changing levels of Cdc42 activity, revealing an un-
anticipated way to pharmacologically target and revert
alterations of the epigenetic architecture in aged HSCs
(Fig. 6m).
Methods
Mice
C57BL/6 mice (2–4 months old) were obtained from
Janvier. Aged C57BL/6 mice (20–26 months old) were
obtained from the internal divisional stock (derived from
mice obtained from both The Jackson Laboratory and
Janvier) as well as from NIA/Charles River. Congenic
C57BL/6.SJL-Ptprca/Boy (BoyJ) mice were obtained from
Charles River Laboratories or from the internal div-
isional stock (derived from mice obtained from Charles
River Laboratories). Lmna-floxed mice were kindly pro-
vided by Dr. C. Stewart [45]. To obtain the hematopoietic-
specific knockout of LaminA/C, the Lmna flox mice were
crossed with mice bearing the hematopoietic-specific Vav-
Cre transgene (B6.Cg-Tg (Vav1-Cre) A2Kio/J). Genotyping
of the Lmnafl/fl and LmnaΔ/Δ/Vav-Cre mice was conducted
by a duplex PCR protocol. The conditional deletion was
tested with primers LA-F1 CCAGCTTACAGAGCACC
GAGCT, LA-F2 TCCTTGCAGTCCCTCTTGCATC, and
LA-R1 AGGCACCATTGTCACAGGGTC and for the
presence of Vav1-Cre transgene was used the following
primers: Cre-For 5′ CTTCTAGGCCTGTACGGAAGT
GTT 3′ and Cre-Rev 5′ CGCGCGCCTGAAGATATAG
AAGAT 3′ [45, 46]. The effectiveness of the knock-out
strategy was verified by intracellular flow cytometry and
immunofluorescence staining in hematopoietic stem and
progenitor cells. Antibodies used were anti-LaminAC
(sc-20681), anti-LaminAC (sc-7292) from Santa Cruz Bio-
technology, and anti-Lamin A+C (ab8984) from AbCam.
And all showed only a knockdown of LaminA/C in HSCs,
ranging from a reduction of 50 to 75% of the expression
level. Cdc42GAP mice (9–11 months old) were obtained
from CCHMC [35].
Flow cytometry and cell sorting
PB and BM cell immunostaining was performed accord-
ing to the standard procedures, and samples were ana-
lyzed on a LSRII flow cytometer (BD Biosciences).
Monoclonal antibodies to Ly5.2 (clone 104, eBioscience)
and Ly5.1 (clone A20, eBioscience) were used to distinguish
donor from recipient and competitor cells. For PB and BM
lineage analysis, the antibodies used were all from
eBioscience: anti-CD3ε (clone 145-2C11), anti-B220 (clone
RA3-6B2), anti-Mac-1 (clone M1/70), and anti-Gr-1 (clone
RC57BL/6-8C5). Lineage FACS analysis data are plotted as
the percentage of B220+, CD3+, and myeloid (Gr-1+,
Mac-1+, and Gr-1+Mac-1+) cells among donor-derived cells
in case of a transplantation experiment or among total
white blood cells. As for early hematopoiesis analysis,
mononuclear cells were isolated by low-density centrifuga-
tion (Histopaque 1083, Sigma) and stained with a cocktail
of biotinylated lineage antibodies. Biotinylated antibodies
used for lineage staining were all rat anti-mouse antibodies:
anti-CD11b (clone M1/70), anti-B220 (clone RA3-6B2),
anti-CD5 (clone 53-7.3), anti-Gr-1 (clone RB6-8C5),
anti-Ter119, and anti-CD8a (clone 53-6.7) (all from
eBioscience). After lineage depletion by magnetic separ-
ation (Dynalbeads, Invitrogen), cells were stained with
anti-Sca-1 (clone D7) (eBioscience), anti-c-kit (clone 2B8)
(eBioscience), anti-CD34 (clone RAM34) (eBioscience),
anti-CD127 (clone A7R34) (eBioscience), anti-Flk-2 (clone
A2F10) (eBioscience), and streptavidin (eBioscience). Early
hematopoiesis FACS analysis data were plotted as a per-
centage of long-term hematopoietic stem cells (LT-HSCs,
gated as LSK CD34-/lowFlk2−), short-term hematopoietic
stem cells (ST-HSCs, gated as LSK CD34+Flk2−), and
lymphoid-primed multipotent progenitors (LMPPs, gated
as LSK CD34+Flk2+) [61] distribution among donor-derived
LSKs (Linnegc-kit+sca-1+ cells). In order to isolate LT-HSCs,
lineage depletion was performed to enrich for
lineage-negative cells. Lineage-negative cells were then
stained as aforementioned and sorted using a BD FACS
Aria III (BD Bioscience). For intracellular flow cytometric
staining, lineage-depleted young, aged, aged±CASIN 5 μM,
and/or aged±NaB 5 mM BM cells were incubated for 16 h
in IMDM+ 10% FBS at 37 °C, 5% CO2, and 3% O2. At the
end of the treatment, the samples were moved on ice and
stained again with the cocktail of biotinylated lineage anti-
bodies. After washing, the samples were stained with
anti-Sca-1 (clone D7) (eBioscience), anti-c-kit (clone 2B8)
(eBioscience), anti-CD34 (clone RAM34) (eBioscience),
anti-Flk-2 (clone A2F10) (eBioscience), and streptavidin
(eBioscience). At the end of the surface staining, cells
were fixed and permeabilized with Cytofix/Cytoperm
Solution (BD Biosciences) and incubated with 10% don-
key serum (Sigma) in BD Perm/Wash Buffer (BD Bio-
sciences) for 30 min. Primary and secondary antibody
incubations were performed at room temperature in
BD Perm/Wash Buffer (BD Biosciences) for 1 h and
30 min, respectively. The secondary antibody for intracel-
lular flow cytometry was a donkey anti-rabbit DyLight649
(BioLegend).
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HSC competitive transplantation
For competitive HSC transplantation, young (2–4-month-
old) and aged (20–26-month-old) C57BL/6 mice (Ly5.2+)
were used as donors. Two hundred HSCs were sorted into
96 multi-well plates and cultured for 16 h in HBSS+ 10%
FBS±CASIN 5 μM or ±NaB (Sigma) 5 mM in a water-
jacketed incubator at 37 °C, 5% CO2, and 3% O2. Stem cells
were then mixed with 3 × 105 BM cells from young (2–
4-month-old) BoyJ competitor mice (Ly5.1+) and trans-
planted into BoyJ recipient mice (Ly5.1+). PB chimerism
was determined by FACS analysis every 8 weeks up to
24 weeks post-primary transplants. The transplantation
experiment was performed four times with a cohort of five
recipient mice per group each transplant. In general, trans-
planted mice were regarded as engrafted when PB chime-
rism was higher or equal to 1.0%, and contribution was
detected in all lineages.
Immunofluorescence staining
Freshly sorted HSCs were seeded on fibronectin-coated
glass coverslips. For polarity staining, HSCs were incu-
bated 12–16 h in HBSS+ 10% FBS and when indicated
treated with CASIN 5 μM or NaB 5 mM or left un-
treated. After incubation at 37 °C, 5% CO2, and 3% O2,
in growth factor-free medium cells were fixed with BD
Cytofix Fixation Buffer (BD Biosciences). After fixation,
the cells were gently washed with PBS, permeabilized
with 0.2% Triton X-100 (Sigma) in PBS for 20 min, and
blocked with 10% donkey serum (Sigma) for 30 min. Pri-
mary and secondary antibody incubations were per-
formed for 1 h at room temperature. Coverslips were
mounted with ProLong Gold Antifade Reagent with or
without DAPI (Invitrogen, Molecular Probes). Samples
were imaged with an AxioObserver Z1 microscope
(Zeiss) equipped with a × 63 PH objective. Images were
analyzed with Zen software. Alternatively, samples were
analyzed with an LSM710 confocal microscope (Zeiss)
equipped with a × 63 objective. Primary raw data were
imported into the Volocity Software package (Version
6.2, Perkin Elmer) for further processing and conversion
into 3D images. As for polarity scoring, the localization
of each single stained protein was considered polarized
when a clear asymmetric distribution was visible by
drawing a line across the middle of the cell or the nu-
cleus. On average, a total of 20 to 150 HSCs were singu-
larly analyzed per sample. Data are plotted as a
percentage of the total number of cells scored per sample.
The primary antibodies were as follows: anti-LaminB
(sc-6217), anti-LaminAC (sc-20681), and anti-LaminAC
(sc-7292) from Santa Cruz Biotechnology; anti-alpha tubu-
lin (ab6160) and anti-Lamin A+C (ab8984) from AbCam;
anti-H4K16ac (07-329) from Millipore; anti-H4K16ac
(39168) from Active Motif; anti-H3K4me3 (ab8580), anti-
H3K4me1 (ab8895), and anti-H3K27ac (ab4729) from
AbCam; and anti-H4K8ac and anti-H4K5ac from Millipore.
The secondary antibodies were anti-rat DyLight488-
conjugated antibody, anti-rat DyLight647-conjugated
antibody, anti-rabbit DyLight549-conjugated antibody,
anti-rabbit DyLight488-conjugated antibody, and anti-
mouse DyLight488-conjugated antibody (all obtained
from Jackson ImmunoResearch).
3D DNA-FISH/Immuno-FISH (fluorescence in situ
hybridization)
DNA and Immuno-FISH were done following the proto-
col by Chaumeil et al. [62]. Whole chromosome paint
probes for chromosomes 3 and 11 (Spectrum Orange)
and 7 and 16 (Spectrum Green) were generated and la-
beled according to Kosyakova et al. [63]. Cells were
mounted with Vectashield antifade mounting medium
with DAPI (Vector Laboratories) and scanned with a Zeiss
LSM710 confocal microscope equipped with a × 63 ob-
jective. Z-stack images were acquired with 0.5 μm inter-
vals and analyzed by Volocity 3D Image Analysis Software
package (Version 6.2.0 Perkin Elmer).
Distance and nuclear shape measurements
Nuclear shape measurement was done based on DAPI
staining of nuclei and analyzed by Volocity 3D Image
Analysis software. Nuclear shape factor (NSF) shows
how similar is a 3D shape to a perfect circle. NSF is 1
for a perfect circle, and the circle becoming smaller for
an irregular shape. “Measure distances” task was used to
automatically measure the distance between two chro-
mosomes from centroid to centroid. The centroid of the
object is calculated by taking the average position of the
voxels making up the object.
3D-structured illumination microscopy
For 3D-structured illumination microscopy (3D-SIM), a
DeltaVision OMX V3 system (Applied Precision, GE
Healthcare) was used, equipped with a × 100/1.40 NA Plan
Apo oil immersion objective (Olympus, Tokyo, Japan),
Cascade II:512 EMCCD cameras (Photometrics, Tucson,
AZ, USA) and 405, 488, and 593 nm diode lasers. Image
stacks were acquired with a z-distance of 125 nm and with
15 raw images per plane (five phases, three angles) result-
ing in an effective lateral and axial resolution of 120 nm
and 300 nm, respectively. To obtain super-resolution
image stacks, raw datasets were reconstructed using
Wiener filter settings 0.004 and channel-specifically
measured optical transfer functions (OTFs) using the
softWoRx 6.0 software package (Applied Precision). To
perform the analysis of nuclear volumes, 32-bit image
stacks were shifted to positive values and converted to
16-bit composite TIFF stacks. Following, image stacks
were imported into TANGO [64] using workflows as
previously described [65]. Briefly, to generate nuclear
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masks, a watershed algorithm was used to segment signals
from the DAPI channel, and morphological filters were
applied to create coherent binary masks. The voxel cover-
age of these masks covering the entire nuclear volume
was exported to Excel, and relevant distributions between
different cell populations were plotted. Finally, to assess
statistical significance, a two-tailed test was performed.
Reverse transcriptase real-time PCR
Immediately after sorting, about 40,000 LT-HSCs from
young and aged mice were lysed and processed for RNA ex-
traction. RNA was extracted with the microRNA Extraction
kit (Qiagen) and was used for cDNA conversion. cDNA
was obtained and amplified with Ovation RNA Amplifica-
tion System V2 (NuGEN). All real-time PCRs were run
with TaqMan real-time PCR reagent and primers from
Applied Biosystem on an ABI 9700HT real-time machine.
Statistical analyses
Data were tested to meet normal distribution. The vari-
ance was similar between the groups that were statisti-
cally compared. All data are plotted as mean + 1
standard error (SEM) unless differently stated. The SEM
is used to indicate the precision of an estimated mean.
Such data representation does not affect the statistical
analyses as variance information is utilized in the statis-
tic tests. A paired Student’s t test was used to determine
the significance of the difference between means of two
groups. One-way ANOVA or two-way ANOVA were
used to compare the means among three or more inde-
pendent groups. Bonferroni post-test to compare all pair
of dataset was determined when the overall p value was
< 0.05. All statistical analyses were determined with
Prism 6.0c version. In order to choose sample size, we
used GraphPad StatMate Software Version 6.0b, estimat-
ing a standard deviation between 2 and 8 (depending on
the experiment and the possibility of increasing sample
size). For transplantation experiments, we estimated a
sample size of 15 to 20 (assuming a standard deviation
of 10 and a significant difference between means of at
least 15). In transplantation experiments, samples were
included in the analysis when engraftment was more or
equal to 0.5% after 24 weeks, and contribution was detected
in all lineages. Mice showing signs of sickness and with
clear alterations of blood parameter and/or showing signs
of major disease involving also non-hematopoietic tissues
were excluded from the analysis. As for in vitro experi-
ments, the samples were excluded from the analysis in case
of clear technical problems (error in immune-blotting or
staining procedures or technical problems with reagents).
All criteria for exclusions of samples from in vivo or in vitro
experiments were pre-established. In each figure, legend in-
dicated the number (n) of biological repeats (samples ob-
tained from experiments repeated in different days and
starting from different mice) included in the final statistical
analysis. Mice for experiments were randomly chosen from
our in-house colonies or suppliers. All mice were C57/Bl6
females unless differently stated. The investigator was
not blinded to the mouse group allocation nor when
assessing the outcome (aged mice or young mice
transplanted with aged BM stem cells require particu-
lar care and follow-up).
Chromatin immunoprecipitation sequencing
Cells were fixed in 1% formalin for 10 min at room
temperature, and fixation was stopped by adding glycine
to a final concentration of 125 mM. After three washes
with PBS, cell pellets were stored at − 80 °C. For sonic-
ation, cell pellets were resuspended in lysis buffer (1%
SDS, 10 mM EDTA, 50 mM Tris, pH 8.1) supplemented
with protease inhibitor cocktail (Roche) and processed
in a Covaris S2 instrument using empirically established
conditions that resulted in chromatin fragments between
150 and 300 bp in length (duty cycle 5%, intensity 4, cy-
cles/burst 200; 40 cycles: 30 s on, 20 s off ). Sonicated
chromatin was cleared by centrifugation for 10 min at
13000 rpm. Ten percent of cleared chromatin was taken
as input control. The H4K16ac antibody (Millipore) was
coupled to protein A/G magnetic beads and washed × 2
with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100,
1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM
NaCl). Sonicated chromatin was first diluted 10-fold with
ChIP dilution buffer, then the antibody-bead conjugates
were added and incubated at 4 °C over night. Beads were
first washed × 2 with Low Salt Immune Complex Wash
Buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris-HCl, pH 8.1, 150 mM NaCl) and then washed × 2
with LiCl Immune Complex Wash Buffer (0.25 M LiCl,
1% IGEPAL CA630, 1% deoxycholic acid (sodium salt),
1 mM EDTA, 10 mM Tris, pH 8.1). Then, precipitated
chromatin was eluted and decrosslinked (2% SDS, 0.1 M
NaHCO3, 0.25 M NaCl) for 4 h at 65 °C and afterwards
treated with proteinase K for 1 h at 45 °C. DNA was puri-
fied using SPRI beads (Agencourt AMPure XP, Beckman
Coulter) at a ratio of 1.8/1 (beads/DNA) and eluted in
15 μl ddH2O. Linear DNA amplification (LinDA) of
ChIPed DNA was performed as described [66]. Briefly,
ChIPed DNA was dephosphorylated for 10 min at 37 °C
using 1 U TSAP (M9910, Promega) in NEB 4 buffer
(B7004, NEB) followed by heat inactivation for 15 min at
75 °C. DNA was then T tailed for 20 min at 37 °C in the
presence of 5 μM T-mix (92% dTTP, 8% ddCTP) and
0.25 mM CoCl2 using 20 U terminal transferase (M0252,
NEB) followed by heat inactivation for 10 min at 70 °C.
Next, 5 pmol T7-BpmI-oligo(A)14 primer (AATTAATAC
GACTCACTATAGGGCTGGAGAAAAAAAAAAAAAA)
was annealed at 37 °C for 5 min and then double strand
synthesis was performed for 55 min at 37 °C using 10 U
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Klenow fragment (M0210, NEB), 0.2 mM dNTPs. After
heat inactivation, DNA was purified using SPRI beads at a
ratio of 1.8/1 (beads/DNA) and eluted in 12.5 μl ddH2O. In
vitro transcription was performed overnight using the
RNAMaxx high yield kit (200339, Stratagene), and the
resulting RNA was purified using SPRI beads (Agencourt
AMPure XP, Beckman Coulter; beads/DNA ratio 1.8/1)
followed by a reverse transcription (1 h, 42 °C;
10 min, 75 °C) using the T7-BpmI-oligo(A)14 primer
and the Superscript III reverse transcription kit (18080044,
Invitrogen). Second strand synthesis was performed using a
custom reaction (20 μl first strand cDNA, 10 μl × 10 ther-
mopol buffer, 1 ml × 100 BSA, 3 ml 10 mM dNTPs, 0.5 μl
RnaseH, 1 μl Taq polymerase, 0.1 μl Pfu polymerase,
64.4 ml H2O) which was incubated in a thermocycler under
the following conditions: 37 °C 5 min, 65 °C 1 min, 72 °C
30 min) followed by SPRI purification (beads/DNA ratio
1.8/1). Resulting double-stranded DNA was then digested
with BpmI for 2 h at 37 °C, purified again with SPRI beads
(beads/DNA ratio 1.5/1) and eluted in 13 μl ddH2O. Illu-
mina sequencing libraries were prepared using the NEB-
Next Ultra DNA Library Prep Kit for Illumina (E7370,
NEB) and the NEBNext Multiplex-Oligos for Illumina
(E7335, NEB) following the manufacturer’s protocol. Since
for all samples, the input amount of DNA was below
100 ng; the adaptors were diluted 1:10 in sterile water be-
fore adaptor ligation. Cleanup of adaptor-ligated DNA was
performed without size selection using a 1.0/1 ratio of SPRI
beads/DNA. For the PCR amplification of libraries, 0.5 μl
of × 100 Syber Green was added to each reaction and the
PCR amplification was performed on a LightCycler 480
(Roche) using the following cycling conditions: initial de-
naturation (98 °C, 30 s) followed by 9–12 cycles (98 °C,
10 s; 65 °C, 30 s; 72 °C, 30 s). The PCR reaction was
stopped when the amplification curves had reached a fluor-
escence intensity of about 10. The PCR reactions were
purified using SPRI beads at a ratio of 1.0/1 (beads/DNA).
Sequencing libraries were multiplexed and subjected to
50 bp single-end sequencing on an Illumina HiSeq 2000 or
HiSeq 2500 instrument (Illumina Inc., San Diego).
ChIP-seq data can be accessed under Gene Expression
Omnibus (GEO accession number: GSE120232 https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120232).
Sequence alignment and peak calling
Raw reads were trimmed using the trimLinDA script
(available at http://www-igbmc.u-strasbg.fr/Gronemeyer)
[67] mapped to the mouse reference genome (mm10)
using the BWA aligner [68], and subsequently, duplicates
and low-quality reads (MAQ score < 20) were removed
using SAMtools [69]. For peak calling, generation of
bedgraphs, differential binding analysis, and gene annota-
tion, we used the Homer software package (http://homer.
ucsd.edu/homer/download.html) [70]. The histone style
parameters and the appropriate input sample were used to
detect H4K16ac peaks.
RNA-seq sample preparation and analysis
RNA-seq libraries were generated from 1000 pooled young,
aged, and aged CASIN-treated HSCs (n = 4–5 biological re-
peats per sample) using Ovation® Single Cell RNA-Seq Sys-
tem (NuGEN Technologies Inc.). Manufacturer’s protocol
was strictly followed. Briefly, reverse transcription was per-
formed using oligo dT and selective primers to create first
strand cDNA with randomly incorporated degradable nu-
cleotide analog. This is degraded along with the RNA tem-
plate in a downstream process, leaving single-stranded
antisense cDNA fragmented to an average size of 230 nu-
cleotides. Second strand cDNA priming was done using
a forward adaptor with a random octamer attached to
its 5′ end. After performing end repair, the free end of
the newly synthesized double-stranded cDNA was li-
gated to the reverse adaptor and final enrichment PCR
was performed. Samples were sequenced on the Illu-
mina HiSeq2000 platform. The raw paired-end reads
were adapter trimmed and quality filtered (phred score
of > 20) using the cutadapt wrapper trim galore. Fil-
tered sequences were aligned to the mouse genome
mm10 RefSeq using TopHat and processed further
using Cufflinks [71]. All downstream analysis including
differential expression analysis, principal component
analysis, between-group analysis, and additional statis-
tical tests related to RNA-seq were performed using R and
bioconductor packages [72] and in-house-developed
scripts. The GSEA tool from broad MIT [73] was used for
Gene Set Enrichment Analysis (GSEA). RNA-seq data
have been deposited in NCBI’s Gene Expression Omnibus
[74] and are accessible through GEO Series accession
number GSE119466 (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE119466).
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